Basic info
Industry
biotechnology research
Sectors
Biotechnology
Engineered T cell therapy
Cell Therapy
Health Care
CART
Oncology
Hepatocellular Carcinoma
Therapeutics
Immunotherapy
Therapeutic Antibodies
Phage Display
Non-Hodgkin's Lymphoma
Medical
Date founded
2006
Funding rounds raised
Total raised
$45M
from 5 investors over 5 rounds
E
Eureka Therapeutics, Inc raised $45M on March 17, 2020
Investors: Lyell Immunopharma
E
Eureka Therapeutics, Inc raised $21M on September 23, 2014
Investors: ACORN CAMPUS, L.L.C., Harbinger Venture and Majuven
E
Eureka Therapeutics, Inc raised $1.7M on November 13, 2008
Investors: ACORN CAMPUS, L.L.C.